Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Recent papers from Agence Nationale de Recherches sur le Sida et les Hépatites Virales

1. Does a prenatal consultation dedicated to fathers’ health widen men’s access to prevention and care?BMC Health Services Research · 2026
2. SARS-CoV-2 variants circulating in West and Central Africa between 2020 and 2022: A retrospective studyJournal of Infection and Public Health · 2026
3. Evolution of Untreated Anal High-Grade Squamous Intraepithelial Lesions in High-Risk Men: A Prospective 5-Year Clinical Follow-up in the ANRS-EP57-APACHES StudyClinical Infectious Diseases · 2026
4. Comparison of four frailty scores to predict adverse health events and mortality in people living with HIV aged 70 years and more ( ANRS EP 66 SEPTAVIH study)HIV Medicine · 2026
5. Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease2026
6. CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteersScientific Reports · 2026
7. Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines2026
8. CONVICTION-CHIK study on the effect of convalescent plasma for mother-to-child Chikungunya infection: protocol for a multicentre, open label, single-arm, phase II trialBMC Pregnancy and Childbirth · 2026
9. Scoping review on the prioritisation of high-consequence infectious pathogens for research preparedness and response to health emergenciesBMC Medicine · 2026
10. Comparison of Four Assays That Measure Antibodies to Ebola Virus Glycoprotein2026
11. HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravirCommunications Medicine · 2026
12. Comparative evaluation of regression and machine-learning models for hepatocellular carcinoma risk stratification across diverse aetiologiesJHEP Reports · 2026
13. Prophylactic Treatment of Patent Ductus Arteriosus With AcetaminophenJAMA Pediatrics · 2026
14. Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trialBMJ Open · 2026
15. Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trialPLoS neglected tropical diseases · 2026
16. Effectiveness and Implementation of Adapted Physical Activity Delivery Strategies for Older Adults Living With HIV in Ivory Coast: Protocol for a Type 2 Hybrid Randomized Controlled TrialJMIR Research Protocols · 2025
17. Antimicrobial-Resistant Neisseria gonorrhoeae Infections in Men Using Doxycycline Postexposure Prophylaxis: A Substudy of the ANRS 174 DOXYVAC TrialClinical Infectious Diseases · 2025
18. Perceived disabling physical pain and suicidal ideation in aging people living with HIV cured of hepatitis C: A multi‐center survey in France (ANRS CO13 HEPAVIH)HIV Medicine · 2025
19. Acceptance of chikungunya vaccination: a rapid survey in Reunion island during an epidemic.Vaccine · 2025
20. Lessons from the European mpox outbreak: strengthening cohort research for future pandemic preparednessClinical Microbiology and Infection · 2025